The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Syndromic Diagnostic Test Market Research Report 2024
Synopsis
Syndromic diagnostic test is a type of medical test that enables the simultaneous detection and identification of multiple pathogens or disease markers associated with a specific syndrome or set of symptoms. Instead of targeting a single pathogen or condition, syndromic tests utilize advanced technologies like multiplex PCR, microarrays, or next-generation sequencing to identify a range of pathogens or genetic markers in a single analysis. These tests are particularly useful in situations where the exact cause of an illness is unknown or when there is a possibility of multiple disease agents contributing to the symptoms.
The global Syndromic Diagnostic Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Syndromic Diagnostic Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Syndromic Diagnostic Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Syndromic Diagnostic Test in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Syndromic Diagnostic Test include Abbott, Hologic, Applied BioCode, Danaher, Diagenode, Curetis, Bio-Rad, DiaSorin and bioMérieux, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Syndromic Diagnostic Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Syndromic Diagnostic Test.
Report Scope
The Syndromic Diagnostic Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Syndromic Diagnostic Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Syndromic Diagnostic Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Hologic
Applied BioCode
Danaher
Diagenode
Curetis
Bio-Rad
DiaSorin
bioMérieux
QIAGEN
Segment by Type
Nucleic Acid Extraction Test
Polymerase Chain Reaction (PCR) Test
Others
Segment by Application
Hospital
Laboratory
Research Institution
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Syndromic Diagnostic Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Syndromic diagnostic test is a type of medical test that enables the simultaneous detection and identification of multiple pathogens or disease markers associated with a specific syndrome or set of symptoms. Instead of targeting a single pathogen or condition, syndromic tests utilize advanced technologies like multiplex PCR, microarrays, or next-generation sequencing to identify a range of pathogens or genetic markers in a single analysis. These tests are particularly useful in situations where the exact cause of an illness is unknown or when there is a possibility of multiple disease agents contributing to the symptoms.
The global Syndromic Diagnostic Test market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Syndromic Diagnostic Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Syndromic Diagnostic Test is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Syndromic Diagnostic Test in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Syndromic Diagnostic Test include Abbott, Hologic, Applied BioCode, Danaher, Diagenode, Curetis, Bio-Rad, DiaSorin and bioMérieux, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Syndromic Diagnostic Test, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Syndromic Diagnostic Test.
Report Scope
The Syndromic Diagnostic Test market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Syndromic Diagnostic Test market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Syndromic Diagnostic Test companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
Hologic
Applied BioCode
Danaher
Diagenode
Curetis
Bio-Rad
DiaSorin
bioMérieux
QIAGEN
Segment by Type
Nucleic Acid Extraction Test
Polymerase Chain Reaction (PCR) Test
Others
Segment by Application
Hospital
Laboratory
Research Institution
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Syndromic Diagnostic Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Syndromic Diagnostic Test Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nucleic Acid Extraction Test
1.2.3 Polymerase Chain Reaction (PCR) Test
1.2.4 Others
1.3 Market by Application
1.3.1 Global Syndromic Diagnostic Test Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Research Institution
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Syndromic Diagnostic Test Market Perspective (2019-2030)
2.2 Syndromic Diagnostic Test Growth Trends by Region
2.2.1 Global Syndromic Diagnostic Test Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Syndromic Diagnostic Test Historic Market Size by Region (2019-2024)
2.2.3 Syndromic Diagnostic Test Forecasted Market Size by Region (2025-2030)
2.3 Syndromic Diagnostic Test Market Dynamics
2.3.1 Syndromic Diagnostic Test Industry Trends
2.3.2 Syndromic Diagnostic Test Market Drivers
2.3.3 Syndromic Diagnostic Test Market Challenges
2.3.4 Syndromic Diagnostic Test Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Syndromic Diagnostic Test Players by Revenue
3.1.1 Global Top Syndromic Diagnostic Test Players by Revenue (2019-2024)
3.1.2 Global Syndromic Diagnostic Test Revenue Market Share by Players (2019-2024)
3.2 Global Syndromic Diagnostic Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Syndromic Diagnostic Test Revenue
3.4 Global Syndromic Diagnostic Test Market Concentration Ratio
3.4.1 Global Syndromic Diagnostic Test Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Syndromic Diagnostic Test Revenue in 2023
3.5 Syndromic Diagnostic Test Key Players Head office and Area Served
3.6 Key Players Syndromic Diagnostic Test Product Solution and Service
3.7 Date of Enter into Syndromic Diagnostic Test Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Syndromic Diagnostic Test Breakdown Data by Type
4.1 Global Syndromic Diagnostic Test Historic Market Size by Type (2019-2024)
4.2 Global Syndromic Diagnostic Test Forecasted Market Size by Type (2025-2030)
5 Syndromic Diagnostic Test Breakdown Data by Application
5.1 Global Syndromic Diagnostic Test Historic Market Size by Application (2019-2024)
5.2 Global Syndromic Diagnostic Test Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Syndromic Diagnostic Test Market Size (2019-2030)
6.2 North America Syndromic Diagnostic Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Syndromic Diagnostic Test Market Size by Country (2019-2024)
6.4 North America Syndromic Diagnostic Test Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Syndromic Diagnostic Test Market Size (2019-2030)
7.2 Europe Syndromic Diagnostic Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Syndromic Diagnostic Test Market Size by Country (2019-2024)
7.4 Europe Syndromic Diagnostic Test Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Syndromic Diagnostic Test Market Size (2019-2030)
8.2 Asia-Pacific Syndromic Diagnostic Test Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Syndromic Diagnostic Test Market Size by Region (2019-2024)
8.4 Asia-Pacific Syndromic Diagnostic Test Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Syndromic Diagnostic Test Market Size (2019-2030)
9.2 Latin America Syndromic Diagnostic Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Syndromic Diagnostic Test Market Size by Country (2019-2024)
9.4 Latin America Syndromic Diagnostic Test Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Syndromic Diagnostic Test Market Size (2019-2030)
10.2 Middle East & Africa Syndromic Diagnostic Test Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Syndromic Diagnostic Test Market Size by Country (2019-2024)
10.4 Middle East & Africa Syndromic Diagnostic Test Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Syndromic Diagnostic Test Introduction
11.1.4 Abbott Revenue in Syndromic Diagnostic Test Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Hologic
11.2.1 Hologic Company Detail
11.2.2 Hologic Business Overview
11.2.3 Hologic Syndromic Diagnostic Test Introduction
11.2.4 Hologic Revenue in Syndromic Diagnostic Test Business (2019-2024)
11.2.5 Hologic Recent Development
11.3 Applied BioCode
11.3.1 Applied BioCode Company Detail
11.3.2 Applied BioCode Business Overview
11.3.3 Applied BioCode Syndromic Diagnostic Test Introduction
11.3.4 Applied BioCode Revenue in Syndromic Diagnostic Test Business (2019-2024)
11.3.5 Applied BioCode Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher Syndromic Diagnostic Test Introduction
11.4.4 Danaher Revenue in Syndromic Diagnostic Test Business (2019-2024)
11.4.5 Danaher Recent Development
11.5 Diagenode
11.5.1 Diagenode Company Detail
11.5.2 Diagenode Business Overview
11.5.3 Diagenode Syndromic Diagnostic Test Introduction
11.5.4 Diagenode Revenue in Syndromic Diagnostic Test Business (2019-2024)
11.5.5 Diagenode Recent Development
11.6 Curetis
11.6.1 Curetis Company Detail
11.6.2 Curetis Business Overview
11.6.3 Curetis Syndromic Diagnostic Test Introduction
11.6.4 Curetis Revenue in Syndromic Diagnostic Test Business (2019-2024)
11.6.5 Curetis Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Detail
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Syndromic Diagnostic Test Introduction
11.7.4 Bio-Rad Revenue in Syndromic Diagnostic Test Business (2019-2024)
11.7.5 Bio-Rad Recent Development
11.8 DiaSorin
11.8.1 DiaSorin Company Detail
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Syndromic Diagnostic Test Introduction
11.8.4 DiaSorin Revenue in Syndromic Diagnostic Test Business (2019-2024)
11.8.5 DiaSorin Recent Development
11.9 bioMérieux
11.9.1 bioMérieux Company Detail
11.9.2 bioMérieux Business Overview
11.9.3 bioMérieux Syndromic Diagnostic Test Introduction
11.9.4 bioMérieux Revenue in Syndromic Diagnostic Test Business (2019-2024)
11.9.5 bioMérieux Recent Development
11.10 QIAGEN
11.10.1 QIAGEN Company Detail
11.10.2 QIAGEN Business Overview
11.10.3 QIAGEN Syndromic Diagnostic Test Introduction
11.10.4 QIAGEN Revenue in Syndromic Diagnostic Test Business (2019-2024)
11.10.5 QIAGEN Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
